Identification of small molecule inhibitors of the HIV-1 Nucleocapsid-Stem-Loop 3 RNA Complex

Douglas Warui, Anne M. Baranger

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Stem-loop 3 RNA (SL3) in ψ-RNA is a highly conserved motif in different strains of HIV-1 and serves as a principle determinant for viral packaging. Viral encapsulation is critical for viral replication, and disruption of the nucleocapsid-ψ-RNA complex interferes with viral replication. We have used SL3 RNA as a target for identification of small molecule inhibitors of the interactions of nucleocapsid protein (NCp7) and ψ-RNA. We report the use of computational and high-throughput screening approaches to identify 16 compounds that bind SL3 RNA with micromolar affinities. Among the identified ligands, two molecules, compounds 7 and 17, bind with higher affinity to SL3 RNA than to double- and single-stranded RNAs. Four of the 16 SL3 RNA ligands inhibit interactions between SL3 RNA and NCp7 with micromolar inhibition constants. In general, the identified SL3 ligands have simple molecular structures and low molecular weights and are, therefore, possible lead compounds for the development of ligands that target the elements of ψ-RNA of HIV-1 with high affinity and specificity.

Original languageEnglish (US)
Pages (from-to)4132-4141
Number of pages10
JournalJournal of Medicinal Chemistry
Volume55
Issue number9
DOIs
StatePublished - May 10 2012

Fingerprint

Nucleocapsid
HIV-1
RNA
Ligands
Nucleocapsid Proteins
Virus Assembly
Double-Stranded RNA

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Drug Discovery

Cite this

@article{8a724d4e5d5f4b4f926c0b4bc4a2c915,
title = "Identification of small molecule inhibitors of the HIV-1 Nucleocapsid-Stem-Loop 3 RNA Complex",
abstract = "Stem-loop 3 RNA (SL3) in ψ-RNA is a highly conserved motif in different strains of HIV-1 and serves as a principle determinant for viral packaging. Viral encapsulation is critical for viral replication, and disruption of the nucleocapsid-ψ-RNA complex interferes with viral replication. We have used SL3 RNA as a target for identification of small molecule inhibitors of the interactions of nucleocapsid protein (NCp7) and ψ-RNA. We report the use of computational and high-throughput screening approaches to identify 16 compounds that bind SL3 RNA with micromolar affinities. Among the identified ligands, two molecules, compounds 7 and 17, bind with higher affinity to SL3 RNA than to double- and single-stranded RNAs. Four of the 16 SL3 RNA ligands inhibit interactions between SL3 RNA and NCp7 with micromolar inhibition constants. In general, the identified SL3 ligands have simple molecular structures and low molecular weights and are, therefore, possible lead compounds for the development of ligands that target the elements of ψ-RNA of HIV-1 with high affinity and specificity.",
author = "Douglas Warui and Baranger, {Anne M.}",
year = "2012",
month = "5",
day = "10",
doi = "10.1021/jm2007694",
language = "English (US)",
volume = "55",
pages = "4132--4141",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "9",

}

Identification of small molecule inhibitors of the HIV-1 Nucleocapsid-Stem-Loop 3 RNA Complex. / Warui, Douglas; Baranger, Anne M.

In: Journal of Medicinal Chemistry, Vol. 55, No. 9, 10.05.2012, p. 4132-4141.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Identification of small molecule inhibitors of the HIV-1 Nucleocapsid-Stem-Loop 3 RNA Complex

AU - Warui, Douglas

AU - Baranger, Anne M.

PY - 2012/5/10

Y1 - 2012/5/10

N2 - Stem-loop 3 RNA (SL3) in ψ-RNA is a highly conserved motif in different strains of HIV-1 and serves as a principle determinant for viral packaging. Viral encapsulation is critical for viral replication, and disruption of the nucleocapsid-ψ-RNA complex interferes with viral replication. We have used SL3 RNA as a target for identification of small molecule inhibitors of the interactions of nucleocapsid protein (NCp7) and ψ-RNA. We report the use of computational and high-throughput screening approaches to identify 16 compounds that bind SL3 RNA with micromolar affinities. Among the identified ligands, two molecules, compounds 7 and 17, bind with higher affinity to SL3 RNA than to double- and single-stranded RNAs. Four of the 16 SL3 RNA ligands inhibit interactions between SL3 RNA and NCp7 with micromolar inhibition constants. In general, the identified SL3 ligands have simple molecular structures and low molecular weights and are, therefore, possible lead compounds for the development of ligands that target the elements of ψ-RNA of HIV-1 with high affinity and specificity.

AB - Stem-loop 3 RNA (SL3) in ψ-RNA is a highly conserved motif in different strains of HIV-1 and serves as a principle determinant for viral packaging. Viral encapsulation is critical for viral replication, and disruption of the nucleocapsid-ψ-RNA complex interferes with viral replication. We have used SL3 RNA as a target for identification of small molecule inhibitors of the interactions of nucleocapsid protein (NCp7) and ψ-RNA. We report the use of computational and high-throughput screening approaches to identify 16 compounds that bind SL3 RNA with micromolar affinities. Among the identified ligands, two molecules, compounds 7 and 17, bind with higher affinity to SL3 RNA than to double- and single-stranded RNAs. Four of the 16 SL3 RNA ligands inhibit interactions between SL3 RNA and NCp7 with micromolar inhibition constants. In general, the identified SL3 ligands have simple molecular structures and low molecular weights and are, therefore, possible lead compounds for the development of ligands that target the elements of ψ-RNA of HIV-1 with high affinity and specificity.

UR - http://www.scopus.com/inward/record.url?scp=84861016261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861016261&partnerID=8YFLogxK

U2 - 10.1021/jm2007694

DO - 10.1021/jm2007694

M3 - Article

C2 - 22480197

AN - SCOPUS:84861016261

VL - 55

SP - 4132

EP - 4141

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 9

ER -